Business Description
PExA AB
ISIN : SE0007412374
Share Class Description:
FRA:FA0: Class BCompare
Compare
Traded in other countries / regions
PEXA B.SwedenFA0.Germany IPO Date
2023-07-14Description
PExA AB develops, manufactures and markets a research tool to study respiratory diseases including asthma and chronic obstructive pulmonary disease, COPD. Its product includes PExA 2.0.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.89 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 1.23 | |||||
| Beneish M-Score | 0.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.2 | |||||
| 3-Year EBITDA Growth Rate | 22.2 | |||||
| 3-Year EPS without NRI Growth Rate | 25.5 | |||||
| 3-Year FCF Growth Rate | 22.9 | |||||
| 3-Year Book Growth Rate | -19.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58 | |||||
| 9-Day RSI | 59.3 | |||||
| 14-Day RSI | 58.17 | |||||
| 6-1 Month Momentum % | -27.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.43 | |||||
| Quick Ratio | 6.27 | |||||
| Cash Ratio | 5.74 | |||||
| Days Inventory | 758.89 | |||||
| Days Sales Outstanding | 73.52 | |||||
| Days Payable | 124.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.02 | |||||
| Operating Margin % | -467.5 | |||||
| Net Margin % | -441.54 | |||||
| FCF Margin % | -471.7 | |||||
| ROE % | -53.04 | |||||
| ROA % | -46.42 | |||||
| ROIC % | -178.13 | |||||
| ROC (Joel Greenblatt) % | -330.67 | |||||
| ROCE % | -53.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 10.45 | |||||
| PB Ratio | 1.72 | |||||
| Price-to-Tangible-Book | 1.79 | |||||
| EV-to-EBIT | -1.44 | |||||
| EV-to-EBITDA | -1.48 | |||||
| EV-to-Revenue | 6.31 | |||||
| EV-to-FCF | -1.29 | |||||
| Price-to-Net-Current-Asset-Value | 1.79 | |||||
| Price-to-Net-Cash | 3.58 | |||||
| Earnings Yield (Greenblatt) % | -69.82 | |||||
| FCF Yield % | -42.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PExA AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.159 | ||
| EPS (TTM) (€) | -0.017 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 58.17 | ||
| 14-Day ATR (€) | 0.002545 | ||
| 20-Day SMA (€) | 0.03252 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 0.0252 - 0.0496 | ||
| Shares Outstanding (Mil) | 42.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PExA AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PExA AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
PExA AB Frequently Asked Questions
What is PExA AB(FRA:FA0)'s stock price today?
The current price of FRA:FA0 is €0.04. The 52 week high of FRA:FA0 is €0.05 and 52 week low is €0.03.
When is next earnings date of PExA AB(FRA:FA0)?
The next earnings date of PExA AB(FRA:FA0) is 2024-08-23.
Does PExA AB(FRA:FA0) pay dividends? If so, how much?
PExA AB(FRA:FA0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers